What they were paid
Voyager Therapeutics Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $51,000 | $0 | $53,760 | $0 | $104,760 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Voyager Therapeutics, Inc. DEF 14A filed April 28, 2026, accession 0001104659-26-050297, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Voyager Therapeutics pays directors a $40,000 cash retainer.
Committees
FY2025 · as the proxy prints themCompensation · Science and Technology
The rest of the Voyager Therapeutics board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Alfred Sandrock | Director | $0 |
| Catherine J. Mackey | Independent Director | $106,760 |
| George Scangos | Independent Director | $103,760 |
| Grace E. Colón | Independent Director | $107,760 |
| James A. Geraghty | Independent Director | $107,260 |
| Jude Onyia | Director | $98,760 |
| Michael Higgins | Chair of the Board | $146,260 |
| Nancy Vitale | Independent Director | $108,760 |
| Steven Hyman | Independent Director | $107,760 |
The full Voyager Therapeutics compensation record
free company briefThis page is one director within Voyager Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat